Compliance takeaways from FDA’s final ‘intended use’ rule
By 
Jaclyn Jaeger2021-09-07T19:08:00
The U.S. Food and Drug Administration’s “intended use” final rule reaffirms the agency’s wide latitude of discretion in establishing an off-label use case against pharmaceutical and medical device companies.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefFDA bans Red No. 3 dye after decades of concerns over possible health risks
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
-
ArticleCW AI event: Boards eager for AI adoption, but governance lags
A “massive” surge in corporate leadership in adopting artitifical intelligence (AI) has been coupled with gaps in AI guardrails, according to a former Google executive speaking at a Compliance Week event on AI use in compliance.
-
ArticleSEC closes FCPA probe into Calavo Growers
The Securities and Exchange Commission has closed its Foreign Corrupt Practices Act investigation into Calavo Growers, three months after the Department of Justice closed its FCPA investigation into the produce and agriculture company.
More from Regulatory Policy
-
ArticleU.K. Employment Rights Act will lead to rise in tribunal claims
The number of U.K. employment tribunal cases could rise following reforms in the Employment Rights Act 2025. Several changes take effect this year, including shorter unfair dismissal qualifying periods, day-one worker rights, stronger protections for pregnant women, and an end to exploitative contracts.
-
ArticleU.K. government scraps long-awaited audit reforms to prioritize growth
Long-awaited reforms to the U.K. audit regime have been “scrapped” from the government’s legislative plans. The decision has led to an outburst of disappointment and frustration from audit bodies and pension funds that argued the reforms would increase trust in companies and support growth.
-
News BriefCFPB, DOJ withdraw guidance to lenders considering borrowers’ immigration status
Two months after the U.S. Consumer Financial Protection Bureau proposed a rule change to narrow anti-discrimination requirements for lenders, it has reversed previous guidance on noncitizen customers looking to borrow.